Bio‐distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)
Open Access
- 15 January 2010
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (2) , 301-310
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Endothelial cell protein C receptor cellular localization and trafficking: potential functional implicationsBlood, 2009
- Successful treatment of canine hemophilia by continuous expression of canine FVIIaBlood, 2009
- Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitorsHaemophilia, 2008
- Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia BJournal of Thrombosis and Haemostasis, 2007
- Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia CentresHaemophilia, 2007
- Tissue factor around dermal vessels has bound factor VII in the absence of injuryJournal of Thrombosis and Haemostasis, 2007
- Endothelial Cell Protein C Receptor Acts as a Cellular Receptor for Factor VIIa on EndotheliumJournal of Biological Chemistry, 2007
- Prophylactic recombinant factor VIIa in haemophilia patients with inhibitorsHaemophilia, 2005
- Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiencyHaemophilia, 2004
- Accumulation of the Recombinant Factor VIIa in Rat Bone: Importance of the Gla‐Domain and Relevance to Factor IX, another Vitamin K‐Dependent Clotting FactorBasic & Clinical Pharmacology & Toxicology, 1993